Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards

Photo of Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards
Facebook
VKontakte
share_fav

A top candidate to head the agency, Jim O’Neill, advocates “progressive” approval, in which drugs proved safe could be sold to consumers even if not yet proved effective.

view The New York Times: Health
#regulation and deregulation of industry
#medical devices